Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Biliary Tract Neoplasms × Trastuzumab × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 20 Stomach Neoplasms 6 Neoplasms 4 Neoplasm Metastasis 4 Esophageal Neoplasms 4 Colorectal Neoplasms 4 Adenocarcinoma Of Esophagus 3 Triple Negative Breast Neoplasms 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Lung Neoplasms 2 HER2-positive Breast Cancer 2 Carcinoma, Non-Small-Cell Lung 2 Brain Neoplasms 2 Adenocarcinoma 2 Uterine Cervical Neoplasms 1 Solid Tumors 1 Resectable HER2-positive Breast Cancer 1 Rectal Neoplasms 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Meningeal Neoplasms 1 Malignant Solid Neoplasm 1 Hemangiosarcoma 1 HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients 1 HER2-positive Gastric Cancer 1 HER2-positive Early Breast Cancer 1 Gastroesophageal Adenocarcinoma 1 Gallbladder Neoplasms 1 Endometrial Neoplasms 1

Interventions

durvalumab 5 Gemcitabine 5 Cisplatin 4 Nivolumab 3 Liquid Biopsy 3 pembrolizumab 2 S 1 (combination) 2 Oxaliplatin 2 Carboplatin 2 zanidatamab 1 trifluridine tipiracil drug combination 1 mitazalimab 1 lenvatinib 1 gemcitabine-oxaliplatin regimen 1 Tegafur 1 Standard of Care 1 Paclitaxel 1 Leucovorin 1 Injections 1 Immune Checkpoint Inhibitors 1 Folfox protocol 1 Fluorouracil 1 Drug Therapy 1 Circulating Tumor DNA 1 Chemotherapy, Adjuvant 1 Capecitabine 1 Blood Specimen Collection 1 Bevacizumab 1 Base Sequence 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡